Nextech Invest AG, a Zurich, Switzerland-based, oncology fund manager, has closed its fourth fund, Nextech Oncology Fund IV, with an investment of $64 million. The funds were supplied by limited partners based in the US, Europe and Asia. ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News Finance, Grants, Deals
